Software - Application
Compare Stocks
4 / 10Stock Comparison
DAVE vs ENVA vs PRAA vs AFRM
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Credit Services
Financial - Credit Services
Software - Infrastructure
DAVE vs ENVA vs PRAA vs AFRM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Application | Financial - Credit Services | Financial - Credit Services | Software - Infrastructure |
| Market Cap | $3.35B | $4.30B | $803M | $22.44B |
| Revenue (TTM) | $552M | $3.15B | $1.24B | $3.20B |
| Net Income (TTM) | $225M | $327M | $-305M | $382M |
| Gross Margin | 81.5% | 50.1% | 99.2% | 62.6% |
| Operating Margin | 4.9% | 23.5% | 33.9% | 10.2% |
| Forward P/E | 19.1x | 10.5x | 25.9x | 62.5x |
| Total Debt | $75M | $4.56B | $32M | $7.85B |
| Cash & Equiv. | $81M | $72M | $104M | $1.35B |
DAVE vs ENVA vs PRAA vs AFRM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| Dave Inc. (DAVE) | 100 | 79.0 | -21.0% |
| Enova International… (ENVA) | 100 | 503.8 | +403.8% |
| PRA Group, Inc. (PRAA) | 100 | 55.4 | -44.6% |
| Affirm Holdings, In… (AFRM) | 100 | 95.5 | -4.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DAVE vs ENVA vs PRAA vs AFRM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DAVE carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 47.5%, EPS growth 222.9%, 3Y rev CAGR 35.7%
- 47.5% revenue growth vs PRAA's 10.4%
- 40.8% margin vs PRAA's -24.6%
- +131.2% vs AFRM's +30.7%
ENVA is the #2 pick in this set and the best alternative if long-term compounding and defensive is your priority.
- 20.3% 10Y total return vs DAVE's -20.5%
- Beta 1.48, current ratio 0.23x
- Lower P/E (10.5x vs 62.5x)
- Beta 1.48 vs AFRM's 2.72
PRAA is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 1.82
- Lower volatility, beta 1.82, Low D/E 3.1%, current ratio 1.68x
AFRM lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 47.5% revenue growth vs PRAA's 10.4% | |
| Value | Lower P/E (10.5x vs 62.5x) | |
| Quality / Margins | 40.8% margin vs PRAA's -24.6% | |
| Stability / Safety | Beta 1.48 vs AFRM's 2.72 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +131.2% vs AFRM's +30.7% | |
| Efficiency (ROA) | 49.6% ROA vs PRAA's -5.9%, ROIC 11.1% vs 11.2% |
DAVE vs ENVA vs PRAA vs AFRM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DAVE vs ENVA vs PRAA vs AFRM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PRAA leads in 3 of 6 categories
DAVE leads 1 • ENVA leads 1 • AFRM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — DAVE and PRAA each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AFRM is the larger business by revenue, generating $3.2B annually — 5.8x DAVE's $552M. DAVE is the more profitable business, keeping 40.8% of every revenue dollar as net income compared to PRAA's -24.6%. On growth, DAVE holds the edge at +36.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $552M | $3.2B | $1.2B | $3.2B |
| EBITDAEarnings before interest/tax | $33M | $815M | $431M | $533M |
| Net IncomeAfter-tax profit | $225M | $327M | -$305M | $382M |
| Free Cash FlowCash after capex | $327M | $1.9B | -$90M | $787M |
| Gross MarginGross profit ÷ Revenue | +81.5% | +50.1% | +99.2% | +62.6% |
| Operating MarginEBIT ÷ Revenue | +4.9% | +23.5% | +33.9% | +10.2% |
| Net MarginNet income ÷ Revenue | +40.8% | +9.8% | -24.6% | +11.9% |
| FCF MarginFCF ÷ Revenue | +59.2% | +56.2% | -7.3% | +24.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +36.7% | — | — | -65.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +104.1% | +28.6% | +2.1% | — |
Valuation Metrics
PRAA leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 14.9x trailing earnings, ENVA trades at a 97% valuation discount to AFRM's 449.1x P/E. On an enterprise value basis, PRAA's 1.7x EV/EBITDA is more attractive than AFRM's 210.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3.4B | $4.3B | $803M | $22.4B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $8.8B | $731M | $28.9B |
| Trailing P/EPrice ÷ TTM EPS | 18.42x | 14.90x | -2.68x | 449.07x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.07x | 10.49x | 25.94x | 62.49x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 69.52x | 11.26x | 1.69x | 209.99x |
| Price / SalesMarket cap ÷ Revenue | 6.55x | 1.37x | 0.65x | 6.96x |
| Price / BookPrice ÷ Book value/share | 10.23x | 3.40x | 0.79x | 7.48x |
| Price / FCFMarket cap ÷ FCF | 11.57x | 2.43x | — | 37.29x |
Profitability & Efficiency
PRAA leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
DAVE delivers a 84.5% return on equity — every $100 of shareholder capital generates $85 in annual profit, vs $-26 for PRAA. PRAA carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENVA's 3.41x. On the Piotroski fundamental quality scale (0–9), ENVA scores 6/9 vs PRAA's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +84.5% | +24.9% | -26.0% | +11.2% |
| ROA (TTM)Return on assets | +49.6% | +5.2% | -5.9% | +3.1% |
| ROICReturn on invested capital | +11.1% | +10.4% | +11.2% | -0.7% |
| ROCEReturn on capital employed | +12.9% | +13.5% | +8.7% | -0.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.21x | 3.41x | 0.03x | 2.56x |
| Net DebtTotal debt minus cash | -$5M | $4.5B | -$72M | $6.5B |
| Cash & Equiv.Liquid assets | $81M | $72M | $104M | $1.4B |
| Total DebtShort + long-term debt | $75M | $4.6B | $32M | $7.9B |
| Interest CoverageEBIT ÷ Interest expense | 22.86x | 79.01x | 0.06x | 1.88x |
Total Returns (Dividends Reinvested)
DAVE leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENVA five years ago would be worth $46,811 today (with dividends reinvested), compared to $5,317 for PRAA. Over the past 12 months, DAVE leads with a +131.2% total return vs AFRM's +30.7%. The 3-year compound annual growth rate (CAGR) favors DAVE at 2.6% vs PRAA's -15.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +13.6% | +6.5% | +19.5% | -9.0% |
| 1-Year ReturnPast 12 months | +131.2% | +87.8% | +57.2% | +30.7% |
| 3-Year ReturnCumulative with dividends | +4740.2% | +302.0% | -39.3% | +464.2% |
| 5-Year ReturnCumulative with dividends | -20.2% | +368.1% | -46.8% | +24.7% |
| 10-Year ReturnCumulative with dividends | -20.5% | +2034.9% | -32.2% | -30.7% |
| CAGR (3Y)Annualised 3-year return | +2.6% | +59.0% | -15.3% | +78.0% |
Risk & Volatility
ENVA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ENVA is the less volatile stock with a 1.48 beta — it tends to amplify market swings less than AFRM's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ENVA currently trades 97.6% from its 52-week high vs AFRM's 67.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.69x | 1.48x | 1.82x | 2.72x |
| 52-Week HighHighest price in past year | $287.69 | $176.68 | $22.55 | $100.00 |
| 52-Week LowLowest price in past year | $105.83 | $89.00 | $10.25 | $42.09 |
| % of 52W HighCurrent price vs 52-week peak | +86.6% | +97.6% | +92.6% | +67.4% |
| RSI (14)Momentum oscillator 0–100 | 51.5 | 65.4 | 61.2 | 63.1 |
| Avg Volume (50D)Average daily shares traded | 607K | 227K | 449K | 5.3M |
Analyst Outlook
PRAA leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: DAVE as "Buy", ENVA as "Buy", PRAA as "Hold", AFRM as "Buy". Consensus price targets imply 24.5% upside for PRAA (target: $26) vs 15.7% for ENVA (target: $200).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $309.25 | $199.50 | $26.00 | $80.77 |
| # AnalystsCovering analysts | 11 | 10 | 13 | 33 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | 2 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.3% | +5.0% | +2.5% | +1.1% |
PRAA leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). DAVE leads in 1 (Total Returns). 1 tied.
DAVE vs ENVA vs PRAA vs AFRM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DAVE or ENVA or PRAA or AFRM a better buy right now?
For growth investors, Dave Inc.
(DAVE) is the stronger pick with 47. 5% revenue growth year-over-year, versus 10. 4% for PRA Group, Inc. (PRAA). Enova International, Inc. (ENVA) offers the better valuation at 14. 9x trailing P/E (10. 5x forward), making it the more compelling value choice. Analysts rate Dave Inc. (DAVE) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DAVE or ENVA or PRAA or AFRM?
On trailing P/E, Enova International, Inc.
(ENVA) is the cheapest at 14. 9x versus Affirm Holdings, Inc. at 449. 1x. On forward P/E, Enova International, Inc. is actually cheaper at 10. 5x.
03Which is the better long-term investment — DAVE or ENVA or PRAA or AFRM?
Over the past 5 years, Enova International, Inc.
(ENVA) delivered a total return of +368. 1%, compared to -46. 8% for PRA Group, Inc. (PRAA). Over 10 years, the gap is even starker: ENVA returned +20. 3% versus PRAA's -32. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DAVE or ENVA or PRAA or AFRM?
By beta (market sensitivity over 5 years), Enova International, Inc.
(ENVA) is the lower-risk stock at 1. 48β versus Affirm Holdings, Inc. 's 2. 72β — meaning AFRM is approximately 84% more volatile than ENVA relative to the S&P 500. On balance sheet safety, PRA Group, Inc. (PRAA) carries a lower debt/equity ratio of 3% versus 3% for Enova International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DAVE or ENVA or PRAA or AFRM?
By revenue growth (latest reported year), Dave Inc.
(DAVE) is pulling ahead at 47. 5% versus 10. 4% for PRA Group, Inc. (PRAA). On earnings-per-share growth, the picture is similar: Dave Inc. grew EPS 222. 9% year-over-year, compared to -535. 2% for PRA Group, Inc.. Over a 3-year CAGR, DAVE leads at 35. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DAVE or ENVA or PRAA or AFRM?
Dave Inc.
(DAVE) is the more profitable company, earning 38. 3% net margin versus -24. 6% for PRA Group, Inc. — meaning it keeps 38. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRAA leads at 33. 9% versus -2. 7% for AFRM. At the gross margin level — before operating expenses — PRAA leads at 99. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DAVE or ENVA or PRAA or AFRM more undervalued right now?
On forward earnings alone, Enova International, Inc.
(ENVA) trades at 10. 5x forward P/E versus 62. 5x for Affirm Holdings, Inc. — 52. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRAA: 24. 5% to $26. 00.
08Which pays a better dividend — DAVE or ENVA or PRAA or AFRM?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is DAVE or ENVA or PRAA or AFRM better for a retirement portfolio?
For long-horizon retirement investors, Enova International, Inc.
(ENVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Affirm Holdings, Inc. (AFRM) carries a higher beta of 2. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ENVA: +20. 3%, AFRM: -30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DAVE and ENVA and PRAA and AFRM?
These companies operate in different sectors (DAVE (Technology) and ENVA (Financial Services) and PRAA (Financial Services) and AFRM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DAVE is a small-cap high-growth stock; ENVA is a small-cap high-growth stock; PRAA is a small-cap quality compounder stock; AFRM is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.